共 58 条
[1]
Bardy GH(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 225-237
[2]
Lee KL(1996)Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1933-1940
[3]
Mark DB(2015)Lead-dependent infective endocarditis: the role of factors predisposing to its development in an analysis of 414 clinical cases Pacing Clin Electrophysiol 38 846-856
[4]
Moss AJ(2011)Inappropriate implantable cardioverter–defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 556-562
[5]
Hall WJ(2017)2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America J Am Coll Cardiol 70 776-803
[6]
Cannom DS(2019)Prophylactic implantable cardioverter-defibrillator in the very elderly Europace 21 1063-1069
[7]
Polewczyk A(2008)Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 288-296
[8]
Jachec W(2012)Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death J Am Coll Cardiol 60 1647-1655
[9]
Janion M(2012)Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators Heart Rhythm 9 42-46
[10]
van Rees JB(2012)Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score Heart 98 872-877